Literature DB >> 23475421

Salvaged failed roof rings and antiprotrusion cages: surgical options and implant survival.

Suksan Tangsataporn1, Mansour Abolghasemian, Paul R Kuzyk, David J Backstein, Oleg A Safir, Allan E Gross.   

Abstract

INTRODUCTION: Failed acetabular reinforcement rings (ARR) (roof rings and antiprotrusion cages) may require another ARR reconstruction or another type of acetabular device with or without a bone graft. The purpose of this study was to propose surgical options for salvage of failed ARRs and to compare the failure rate of each surgical option.
MATERIALS AND METHODS: We reviewed 33 first ARRs (12 roof rings and 21 antiprotrusion cages) which were revised and converted to a new acetabular reconstruction. Operative reports, radiographs, 
and clinical data were evaluated. Minimum follow-up was 24 months (average 57 months; range 24-209 months).
RESULTS: 33 failed first ARRs were converted to one of three types of acetabular reconstruction, Trabecular Metal (TM) cup in 14, cup-cage in 7 and a second ARR in 12. The TM cup group (TM cup and cup-cage) had a significantly longer survival than the second ARR group (P = 0.025) on log-rank analysis. DISCUSSION: Treatment of a failed first ARR by a TM cup and a cup-cage provides better results when compared to treatment by a second ARR. Restoration of bone stock is the main factor in determining whether a TM cup or cup-cage rather than another conventional ARR can be used.

Mesh:

Year:  2013        PMID: 23475421     DOI: 10.5301/hipint.5000009

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  2 in total

Review 1.  Acetabular reinforcement rings associated with allograft for severe acetabular defects.

Authors:  Emmanuel Gibon; Luc Kerboull; Jean-Pierre Courpied; Moussa Hamadouche
Journal:  Int Orthop       Date:  2018-09-13       Impact factor: 3.075

2.  Promising Mid-term Results With a Cup-cage Construct for Large Acetabular Defects and Pelvic Discontinuity.

Authors:  Tomas Amenabar; Wael A Rahman; Bandar M Hetaimish; Paul R Kuzyk; Oleg A Safir; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2016-02       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.